| Normal Range | Overall (n = 123) | Non-Severe (n = 95) | Severe (n = 28) |
Lymphocyte count, ×109/L | 1.1 - 3.2 | 1.2 (±0.52) | 1.3 (±0.52) | 0.91 (±0.43) |
<1.1 × 109 |
| 43 (34.96%) | 27 (28.42%) | 16 (57.14%) |
1.1 - 3.2 × 109 |
| 67 (54.47%) | 60 (63.16%) | 7 (25%) |
unknown |
| 13 (10.57%) | 8 (8.42%) | 5 (17.86%) |
Erythrocyte sedimentation rate (ESR), umol/L | 59 - 104 | 38 (±24) | 35 (±24) | 47 (±24) |
<59 |
| 68 (55%) | 56 (59%) | 12 (43%) |
59 - 104 |
| 12 (10%) | 8 (8%) | 4 (14%) |
Unknown |
| 43 (35%) | 31 (33%) | 12 (43%) |
Blood glucose, mmol/L | 3.9 - 6.11 | 13 (± 53) | 14 (± 60) | 9.1 (± 5.1) |
3.9 - 6.11 |
| 44 (36%) | 36 (38%) | 8 (29%) |
>6.11 |
| 62 (50%) | 47 (49%) | 15 (54%) |
Unknown |
| 17 (14%) | 12 (13%) | 5 (18%) |
Aspartate aminotransferase, U/L | 15 - 40 | 30 (±17) | 26 (±11) | 40 (±28) |
15 - 40 |
| 91 (74.0%) | 73 (80.2%) | 18 (19.8%) |
>40 |
| 17 (13.8%) | 10 (57.8%) | 7 (42.2%) |